Real-World Evidence Integration into Cancer HTA...

By João L. Carapinha

April 1, 2026

How is real-world evidence integration a routine part of Health Technology Assessment (HTA) for cancer medicines in Scotland? Through a successful collaboration between the Cancer Medicines Outcomes Programme–Public Health Scotland (CMOP-PHS) and ...
Personalised Fertility Endometriosis Care in the UK
EU-India Pharmaceutical Trade: Opportunities and Challenges in Biopharmaceuti...
Nonclinical Safety Testing with Virtual Control Groups
Advancing Health Technology Assessment MENA: Insights and Implications for th...
Advancing Participatory Arts Health in Dutch Care Systems
Tarlatamab for Small Cell Lung Cancer Treatment
FDA Approves Once-Weekly Basal Insulin Awiqli® for Type 2 Diabetes Management
Inflation Reduction Act Impact on Clinical Trial Investment Trends
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application A...
South Africa Health Reform: Revitalizing the Crisis-Stricken Sector
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer T...
PEPFAR TB Impact: Averting Millions of Cases and Deaths Among HIV Patients